A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN), a consortium comprising research groups from UCSF, the University of Chicago and the University of Toronto, will support the development of next-generation, antibody-based cancer therapies.

The UCSF School of Medicine welcomed 153 new students to the class of 2019 with a very different kind of orientation, focused on communication and racial bias.

Fetuses with enlarged ventricles may be less likely than other fetuses to benefit from surgery in the womb to treat spina bifida, according to a study co-authored by researchers at UCSF Benioff Children’s Hospital San Francisco.

UCSF has received a National Cancer Institute grant of $5 million over the next five years to lead a massive effort to integrate the data from all experimental models across all types of cancer.

Video games are not adequately rated for tobacco content, according to a new UCSF study that found video gamers are being widely exposed to tobacco imagery.

Heart and lung transplant recipients are living longer than ever before, thanks to rapid advances in technology, medications and surgical procedures. That progress was cause for celebration last month at UCSF, where 400 patients and families gathered.

UCSF will take a key role in convening the Personalized Medicine World Conference next year.